An advisory panel to the US Food and Drug Administration voted for authorizing Pfizer and BioNTech's SARS-CoV-2 vaccine, the Wall Street Journal reports.
Early trial data of a Sanofi and GlaxoSmithKline SARS-CoV-2 vaccine indicates an insufficient immune response among older participants, according to Reuters.
In Science this week: CRISPR and expression-reported sequencing approach to trace genetic interactions, sample preparation platform for single-cell sequencing, and more.
In Nature this week: donkey genome gives insight into domestication, workflow for reference-free assembly of fully phased diploid human genomes, and more.
In Genome Biology this week: relapse-linked mutations in T cell acute lymphoblastic leukemia, single-cell atlas of human tissue transcriptomes, and more.
According to the Guardian, researchers have uncovered a set of proteins that might be able to predict whether COVID-19 patients will need intensive care.
The Washington Post reports officials expect fewer SARS-CoV-2 vaccine doses to be available by the end of the year than was predicted earlier in the pandemic.
